Rhox13 inhibitors are a class of chemical compounds designed to specifically target and inhibit the function of Rhox13, a member of the Rhox (Reproductive Homeobox) gene family. Rhox13 is a transcription factor involved in regulating the expression of genes critical for reproductive and developmental processes. Like other homeobox genes, Rhox13 contains a conserved DNA-binding domain, which allows it to bind to specific sequences in the genome, modulating the transcription of genes involved in cellular differentiation, growth, and the development of reproductive tissues. Inhibitors of Rhox13 work by binding to functional regions of the protein, such as its DNA-binding domain or other regulatory domains, thereby preventing Rhox13 from interacting with its target genes. This interference disrupts Rhox13's ability to regulate gene expression, which can lead to downstream changes in cellular function and development.
By inhibiting Rhox13, these compounds cause significant disruptions in the transcriptional networks regulated by this transcription factor. The alteration in gene expression affects developmental pathways and cellular processes that are heavily reliant on Rhox13's regulatory influence, particularly in reproductive tissues. Researchers use Rhox13 inhibitors as valuable tools to study the role of Rhox13 in gene regulation and developmental biology, providing insight into how Rhox13 influences complex biological systems. Additionally, these inhibitors are instrumental in exploring the relationships between various members of the Rhox gene family, allowing scientists to understand how different Rhox transcription factors work together to regulate essential biological processes. Furthermore, Rhox13 inhibitors can help elucidate the evolutionary conservation and functional specialization of homeobox genes across different species, offering clues about how transcription factors like Rhox13 have evolved to control specialized functions in development and reproduction. Through these inhibitors, researchers gain a deeper understanding of the molecular mechanisms that govern gene expression during critical stages of development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Triptolide can inhibit the transcription of various genes, potentially reducing Rhox13 expression among others. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This drug causes DNA demethylation and may alter gene expression patterns, potentially including Rhox13. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
It binds to DNA and inhibits transcription of GC-rich promoter regions, possibly impacting Rhox13 expression if its promoter is GC-rich. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D intercalates into DNA, inhibiting transcription initiation and elongation, potentially affecting Rhox13 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, which could decrease Rhox13 expression by impeding mRNA synthesis. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin acts as an adenosine analog that interrupts RNA chain elongation, potentially reducing the expression of genes like Rhox13. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II phosphorylation, potentially leading to reduced transcription of Rhox13. | ||||||
Canertinib | 267243-28-7 | sc-207397 | 10 mg | $260.00 | 3 | |
ICG-001 antagonizes Wnt/β-catenin/TCF-mediated transcription, potentially impacting genes under this pathway's control, such as Rhox13. | ||||||